Pfizer twice-a-day COVID pill

Pfizer now developing twice-a-day COVID pill that must be taking alongside vaccine​

(NATIONAL FILE) – Pharmaceutical megacorporation pfizer is now developing a COVID pill that
is meant to be taken alongside the COVID vaccines that have already made the company a staggering
amount of money. The new pill is expected to be released by the end of the year and will be
required to be taken twice per day.

Success against #COVID19 will likely require both vaccines & treatments,” Pfizer CEO Albert Bourla
said on Wednesday. “We’re pleased to share we’ve started a Phase 2/3 study of our oral antiviral
candidate-specifically designed to combat SARS-CoV-2-in non-hospitalized, low-risk adults.”

Source You do not have permission to view the full content of this post. Log in or register now.

 

[rodey_lyf]

its probably derived from ivermectin, as both are protease inhibitor. they are making great efforts to repackaged ivermectin para hindi mahalata na ivermectin

pero idedelay pa nila yan dahil need pa ibenta mga vaccines

 

[MackriderX]

Hahaha. Negosyo forever big pharmA .

 

[alist1986]

Tama po , nabasa ko yan last March noong initial phase:
You do not have permission to view the full content of this post. Log in or register now.

You do not have permission to view the full content of this post. Log in or register now. po yan - a potent You do not have permission to view the full content of this post. Log in or register now. with potent anti-viral activity against SARS-CoV-2. Sunud-sunod na clinical trials yan for specific target patients.
You do not have permission to view the full content of this post. Log in or register now.

Here are their latest tests dahil marami silang clinical trials including PF-07304814 too. Ang alam ko meron din sila You do not have permission to view the full content of this post. Log in or register now. boosted by You do not have permission to view the full content of this post. Log in or register now. (another protease inhibitor).

You do not have permission to view the full content of this post. Log in or register now.
You do not have permission to view the full content of this post. Log in or register now.
You do not have permission to view the full content of this post. Log in or register now.

Yung Merck (MRK), at partner niya na Ridgeback Biotherapeutics, ay nag-umpisa na ng Phase 3 trial ng oral antiviral You do not have permission to view the full content of this post. Log in or register now. para sa post-exposure prophylaxis of COVID-19 infection.

Yung Japanese Shionogi & Co ay meron din S-217622 (a protease inhibitor similar to the other two) :
You do not have permission to view the full content of this post. Log in or register now.

Note: Yung mga basis ng protease inhibitor candidates ngayon ay sa kanilang kakayahang i-target yung SARS-CoV-2: Mpro - yung SARS-Cov2 main protease. This is the latest passing criteria for possible drug development and trial. IVM also has this capability but no officially accepted completed clinical trial has been approved yet, that is why it is still only allowed on a clinical trial basis as of today - not alone but with recombination of other EUA drugs.

Patuloy yung "Race for the COVID-19 pill" or drug ngayon bukod sa vaccines. Panahon ng "Pharmas" siyempre. Ganyan din naman kapag epidemic season.

Check ninyo na lang lahat ng antivirals for COVID-19 dito from your custom search options:
You do not have permission to view the full content of this post. Log in or register now.

 

[Sarhento Patola]

sa huli gagawa sila ng own brand nila ng ivermectin

 

[rodey_lyf]

syempre kahit na may gamot na di pa nila ilalabas at kahit na meron na avilable sisiraan nila yan para mabenta nila vaccines este injections nila

marketing strategy, tuloy tuloy ang benta ng injections